Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Free Report) rose 75.5% on Wednesday . The company traded as high as $0.14 and last traded at $0.14. Approximately 4,102 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 28,869 shares. The stock had previously closed at $0.08.
Guided Therapeutics Stock Performance
The business has a 50 day moving average of $0.10 and a 200 day moving average of $0.13.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last announced its quarterly earnings results on Monday, May 13th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.01 million during the quarter.
About Guided Therapeutics
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
See Also
- Five stocks we like better than Guided Therapeutics
- Conference Calls and Individual Investors
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Quiet Period Expirations Explained
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Where to Find Earnings Call Transcripts
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
